Marks S - Search Results

1

Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme.

Loutfy M, Ribera E, Florence E, De Wit S, Castagna A, Ryan R, Hill A, Vanaken H, van Delft Y, Marks S. Loutfy M, et al. Among authors: marks s. J Antimicrob Chemother. 2009 Dec;64(6):1341-4. doi: 10.1093/jac/dkp366. Epub 2009 Oct 14. J Antimicrob Chemother. 2009. PMID: 19828488 Clinical Trial. No abstract available.

2

HIV RNA suppression rates after 24 weeks of treatment with etravirine, darunavir/ritonavir and raltegravir in the etravirine early access programme.

Florence E, De Wit S, Castagna A, Ribera E, Hill A, Vanaken H, van Delft Y, Marks S. Florence E, et al. Among authors: marks s. Int J STD AIDS. 2010 Mar;21(3):224-5. doi: 10.1258/ijsa.2009.009425. Epub 2010 Jan 13. Int J STD AIDS. 2010. PMID: 20071441 Clinical Trial. No abstract available.

3

A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population.

Nelson M, Stellbrink HJ, Podzamczer D, Banhegyi D, Gazzard B, Hill A, van Delft Y, Vingerhoets J, Stark T, Marks S. Nelson M, et al. Among authors: marks s. AIDS. 2011 Jan 28;25(3):335-40. doi: 10.1097/QAD.0b013e3283416873. AIDS. 2011. PMID: 21150563

4

Phase 2 double-blind, randomized trial of etravirine versus efavirenz in treatment-naive patients: 48-week results.

Gazzard B, Duvivier C, Zagler C, Castagna A, Hill A, van Delft Y, Marks S. Gazzard B, et al. Among authors: marks s. AIDS. 2011 Nov 28;25(18):2249-58. doi: 10.1097/QAD.0b013e32834c4c06. AIDS. 2011. PMID: 21881478 Clinical Trial.

5

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

Fätkenheuer G, Duvivier C, Rieger A, Durant J, Rey D, Schmidt W, Hill A, van Delft Y, Marks S; SENSE Study Team. Fätkenheuer G, et al. Among authors: marks s. J Antimicrob Chemother. 2012 Mar;67(3):685-90. doi: 10.1093/jac/dkr533. Epub 2011 Dec 29. J Antimicrob Chemother. 2012. PMID: 22210755 Clinical Trial.

6

Cost-effectiveness of expanded latent TB infection testing and treatment: Lynn City, Massachusetts, USA.

Beeler Asay GR, Woodruff R, Sanderson DM, Fisher CF, Marks SM, Green VD, Tibbs AM, Hill AN, Haptu HH, McManus D, Paradise RK, Auguste-Nelson C, Cochran JJ. Beeler Asay GR, et al. Among authors: marks sm. Int J Tuberc Lung Dis. 2024 Jan 1;28(1):21-28. doi: 10.5588/ijtld.22.0654. Int J Tuberc Lung Dis. 2024. PMID: 38178297

7

Prevalence and appropriateness of omeprazole prescription in dogs at a veterinary teaching hospital before and after the publication of the ACVIM consensus statement on the rational administration of gastrointestinal protectants.

Sainz Á, García-Sancho M, Villaescusa A, Rodríguez-Franco F, Díaz-Regañón D, Olmeda P, Marks SL. Sainz Á, et al. Among authors: marks sl. Front Vet Sci. 2024 May 7;11:1352496. doi: 10.3389/fvets.2024.1352496. eCollection 2024. Front Vet Sci. 2024. PMID: 38774912 Free PMC article.

8

Patient experiences with outpatient opioid use disorder treatment before and during COVID-19: results from a survey of Medicaid members.

Marks SJ, Pham H, McCray N, Palazzolo J, Harrell A, Lowe J, Bachireddy C, Guerra L, Cunningham PJ, Barnes AJ. Marks SJ, et al. Am J Drug Alcohol Abuse. 2024 May 17:1-14. doi: 10.1080/00952990.2024.2328543. Online ahead of print. Am J Drug Alcohol Abuse. 2024. PMID: 38759212

9

When Is the Optimal Time to Refer Patients with End-Stage Liver Disease to Palliative Care Specialists? #481.

Ghoshal A, Marks S, Esteban JP. Ghoshal A, et al. Among authors: marks s. J Palliat Med. 2024 Apr 30. doi: 10.1089/jpm.2024.0111. Online ahead of print. J Palliat Med. 2024. PMID: 38686513 No abstract available.

10

Favorable Outcome After Single-kidney Transplantation From Small Donors in Children: A Match-controlled CERTAIN Registry Study.

Schild R, Carvajal Abreu K, Büscher A, Kanzelmeyer N, Lezius S, Krupka K, Weitz M, Prytula A, Printza N, Berta L, Saygılı SK, Sellier-Leclerc AL, Spartà G, Marks SD, Kemper MJ, König S, Topaloglu R, Müller D, Klaus G, Weber S, Oh J, Herden U, Carraro A, Dello Strologo L, Ariceta G, Hoyer P, Tönshoff B, Pape L. Schild R, et al. Among authors: marks sd. Transplantation. 2024 Apr 30. doi: 10.1097/TP.0000000000004993. Online ahead of print. Transplantation. 2024. PMID: 38685197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,351 results

Search Page